A Smaller Regression Test Set Needs a Better Explanation

Lukas
By

Selective regression testing can reduce unnecessary execution. The selection becomes credible when the team can explain why the retained tests address the change and why other evidence remains applicable.

Start with the changed behavior

Identify the requirement or control that is directly affected, then examine related workflows and interfaces. A change to user authentication may affect every action requiring a valid session. A change to one report layout may have a narrower scope unless it also alters data selection or calculation.

For a hypothetical application update, suppose a common date-handling component changes. Tests for scheduling, expiry calculations and report filters may all deserve review. The connection comes from the shared behavior, not from whether each test title includes the word “date.”

Explain inclusion and exclusion

A selection record should identify why each significant test is needed and why relevant existing evidence remains applicable. Grouping tests by a justified dependency can simplify the record, but the rationale should remain specific enough to challenge.

AI may propose a candidate set from linked requirements, risks and prior tests. Reviewers should examine both omissions and unnecessary additions. A proposal that selects nearly everything can appear safe while offering little analytical value. A very small set can appear efficient while missing a shared control.

Consider the strength of existing evidence

Review the version, configuration and execution conditions of previous results. Evidence from an earlier environment may require qualification before reuse. Failed or incomplete tests should not be treated as clean baseline evidence merely because their records exist.

Validfor’s catalogue links AI-assisted impact assessment with requirements and test scenarios. Buyers can examine that connection through change management and testing. The appealing result is a proposed test scope that carries its reasoning into review instead of arriving as an unexplained list.

Efficiency should follow from a well-supported scope. A shorter test set is valuable when the reviewer understands the coverage and the assumptions behind reuse.

In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

Share This Article